2017•药物不良反应杂志Requires access

Drug hypersensitivity syndrome induced by sodium valproate

Shipeng Zhan

Open publisher page 0 citations

Abstract

A 20-year-old male with athetosis received sodium valproate 500 mg twice daily. Twenty days after treatment, the patient developed general erythematous which faded after pressing, increased skin temperature, facial swelling, and enlargement of superficial lymph node in his head and neck. Laboratory tests showed the following values: white blood cell (WBC) 18.3×109/L, neutrophils 0.392, lymphocytes 0.364, monocytes 0.137, eosinophils 0.097, procalcitonin (PCT) 0.3 μg/L, alanine aminotransferase (ALT) 311 U/L, aspartate aminotransferase (AST) 148 U/L, alkaline phosphatase (ALP) 295 U/L, gamma-glutamyl transferase (γ-GT) 169 U/L. The patient was diagnosed as drug induced hypersensitivity syndrome (DIHS). Valproate was withdrawn. He received the symptomatic treatments which included glucocorticoid, antihistamines, liver protection and topical medication. Twenty days later, his erythematous rash were disappeared mainly. Fifty-five days later, his erythematous rash disappeared completely. Laboratory tests showed the following values: WBC 8.6×109/L, eosinophils 0.005, ALT 32 U/L, AST 22 U/L, ALP 66 U/L, γ-GT 67 U/L. Key words: Valproic acid; Hypersensitivity

About this research paper

What this paper is about

A 20-year-old male with athetosis received sodium valproate 500 mg twice daily. Twenty days after treatment, the patient developed general erythematous which faded after pressing, increased skin temperature, facial swelling, and enlargement of superficial lymph node in his head and neck. Laboratory tests showed the following values: white blood cell (WBC) 18.3×109/L, neutrophils 0.392, lymphocytes 0.364, monocytes 0.137, eosinophils 0.097, procalcitonin (PCT) 0.3 μg/L, alanine aminotransferase (ALT) 311 U/L, aspartate aminotransferase (AST) 148 U/L, alkaline phosphatase (ALP) 295 U/L, gamma-glutamyl transferase (γ-GT) 169 U/L. The patient was diagnosed as drug induced hypersensitivity syndrome (DIHS). Valproate was withdrawn. He received the symptomatic treatments which included glucocorticoid, antihistamines, liver protection and topical medication. Twenty days later, his erythematous rash were disappeared mainly. Fifty-five days later, his erythematous rash disappeared completely. Laboratory tests showed the following values: WBC 8.6×109/L, eosinophils 0.005, ALT 32 U/L, AST 22 U/L, ALP 66 U/L, γ-GT 67 U/L. Key words: Valproic acid; Hypersensitivity

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

A 20-year-old male with athetosis received sodium valproate 500 mg twice daily. Twenty days after treatment, the patient developed general erythematous which faded after pressing, increased skin temperature, facial swelling, and enlargement of superficial lymph node in his head and neck. Laboratory tests showed the following values: white blood cell (WBC) 18.3×109/L, neutrophils 0.392, lymphocytes 0.364, monocytes 0.137, eosinophils 0.097, procalcitonin (PCT) 0.3 μg/L, alanine aminotransferase (ALT) 311 U/L, aspartate aminotransferase (AST) 148 U/L, alkaline phosphatase (ALP) 295 U/L, gamma-glutamyl transferase (γ-GT) 169 U/L. The patient was diagnosed as drug induced hypersensitivity syndrome (DIHS). Valproate was withdrawn. He received the symptomatic treatments which included glucocorticoid, antihistamines, liver protection and topical medication. Twenty days later, his erythematous rash were disappeared mainly. Fifty-five days later, his erythematous rash disappeared completely. Laboratory tests showed the following values: WBC 8.6×109/L, eosinophils 0.005, ALT 32 U/L, AST 22 U/L, ALP 66 U/L, γ-GT 67 U/L. Key words: Valproic acid; Hypersensitivity

Key concepts: Rash, Medicine, Valproic Acid, Gastroenterology, Leukopenia, Internal medicine, Hypersensitivity reaction, Epilepsy

Related papers

Back to paper searchBrowse research topicsOriginal source
Drug hypersensitivity syndrome induced by sodium valproate — Research Paper | ScholarLens